Skip to main content
. 2020 Apr 15;5(7):1–8. doi: 10.1001/jamacardio.2020.0799

Table 1. Population Characteristicsa.

Characteristic CARDIA study year 25 examination (n = 2400)
Age, y 50.4 (3.6)
Sex, No. (%)
Women 1376 (57.3)
Men 1024 (42.7)
African American, No. (%) 976 (40.7)
BMI 29.9 (7.1)
Antihypertensive medication use, No. (%) 587 (24.5)
Current smoking, No. (%) 319 (13.3)
Physical activity, EU 345.0 (276.5)
Fasting plasma glucose level, mg/dL 98.7 (26.4)
Total cholesterol level, mg/dL 193.1 (36.4)
Blood pressure parameters, mm Hg
Systolic 117.9 (15.3)
Diastolic 73.3 (10.9)
Visit-to-visit, mm Hg
Systolic ARV 1.16 (2.2)
Diastolic ARV 0.7 (1.8)
Systolic SD 8.5 (4.1)
Diastolic SD 7.1 (2.9)
Systolic VIM 8.4 (3.4)
Diastolic VIM 7.2 (2.8)
Echocardiographic measures
LV mass, g 167.2 (51.4)
LA volume, mL 49.5 (15.5)
LV ejection fraction, % 61.7 (6.9)
Global longitudinal strain, % −15.2 (2.4)
E/é 7.7 (2.2)
é, cm/s 10.6 (2.3)

Abbreviations: ARV, average real variability; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CARDIA, Coronary Artery Risk Development in Young Adults; E, peak early diastolic velocity; é, early peak diastolic mitral annular velocity; E/é, mitral inflow velocity to early diastolic mitral annular velocity; EU, exercise units; LA, left atrial; LV, left ventricular; VIM, variability independent of the mean.

SI unit conversion: To convert glucose to millimoles per liter, multiply by 0.0555; total cholesterol to millimoles per liter, multiply by 0.0259.

a

Data are presented as mean (SD) unless otherwise indicated.